NetApp, Inc. (NTAP) capitalization

SEC pipeline catching up: most recent reported quarter (2026-04-30) isn't incorporated yet — this page is anchored to 2026-01-23 (Q3 2026 · 10-Q). New filings land within a few weekday pipeline runs.

Current snapshot

Market Cap
$19.22B
197.3M shares × $97.42 · as of last filing 2026-01-23
Net Worth
$1.16B
Stockholders' equity · 2026-01-23
Enterprise Value
$18.95B
Market cap + debt − cash
Net Debt
-$274.0M
Debt $2.73B − Cash $3.01B

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-04-25 $18.49B
FY'24 2024-04-26 $21.58B
FY'23 2023-04-28 $13.84B
FY'22 2022-04-29 $16.77B
FY'21 2021-04-30 $16.88B
FY'20 2020-04-24 $10.03B
FY'19 2019-04-26 $18.62B
FY'18 2018-04-27 $18.60B
FY'17 2017-04-28 $11.20B
FY'16 2016-04-29 $7.02B
FY'15 2015-04-24 $11.59B
FY'14 2014-04-25 $12.18B
FY'13 2013-04-26 $12.83B
FY'12 2012-04-27 $15.00B
FY'11 2011-04-29 $20.52B
FY'11 2010-04-30 $12.25B
FY'11 2009-04-24 $6.23B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q3'26 2026-01-23 $19.48B
Q2'25 2025-10-24 $23.56B
Q1'25 2025-07-25 $21.30B
Q4'25 2025-04-25 $17.78B
Q3'25 2025-01-24 $26.21B
Q2'25 2024-10-25 $25.08B
Q1'25 2024-07-26 $26.74B
Q4'24 2024-04-26 $20.87B
Q3'24 2024-01-26 $18.58B
Q2'24 2023-10-27 $15.15B
Q1'24 2023-07-28 $16.68B
Q4'23 2023-04-28 $13.33B
Q3'23 2023-01-27 $14.35B
Q2'23 2022-10-28 $15.27B
Q1'23 2022-07-29 $15.98B
Q4'22 2022-04-29 $16.11B
Q3'22 2022-01-28 $19.78B
Q2'22 2021-10-29 $20.45B
Q1'22 2021-07-30 $18.23B
Q4'21 2021-04-30 $16.58B
Q3'21 2021-01-29 $15.08B
Q2'21 2020-10-30 $9.83B
Q1'21 2020-07-31 $9.83B
Q4'20 2020-04-24 $9.43B
Q3'20 2020-01-24 $13.70B
Q2'20 2019-10-25 $13.22B
Q1'20 2019-07-26 $14.36B
Q4'19 2019-04-26 $17.26B
Q3'19 2019-01-25 $16.25B
Q2'19 2018-10-26 $18.96B
Q1'19 2018-07-27 $21.37B
Q4'18 2018-04-27 $17.73B
Q3'18 2018-01-26 $16.98B
Q2'18 2017-10-27 $12.10B
Q1'18 2017-07-28 $12.09B
Q4'17 2017-04-28 $10.72B
Q3'17 2017-01-27 $10.61B
Q2'17 2016-10-28 $9.59B
Q1'17 2016-07-29 $7.43B
Q4'16 2016-04-29 $6.64B
Q3'16 2016-01-29 $6.49B
Q2'16 2015-10-30 $10.06B
Q1'16 2015-07-31 $9.47B
Q4'15 2015-04-24 $11.05B
Q3'15 2015-01-23 $12.52B
Q2'15 2014-10-24 $13.15B
Q1'15 2014-07-25 $12.54B
Q4'14 2014-04-25 $11.36B
Q3'14 2014-01-24 $15.22B
Q2'14 2013-10-25 $13.75B
Q1'14 2013-07-26 $14.88B
Q4'13 2013-04-26 $12.59B
Q3'13 2013-01-25 $13.18B
Q3'14 2012-11-14
Q2'13 2012-10-26 $10.27B
Q1'13 2012-07-27 $12.22B
Q4'12 2012-04-27 $14.32B
Q3'12 2012-01-27 $13.93B
Q2'12 2011-10-28 $15.64B
Q1'12 2011-07-29 $19.27B
Q1'13 2011-05-06
Q4'11 2011-04-29 $19.34B
Q3'11 2011-01-28 $21.95B
Q2'11 2010-10-29 $20.86B
Q1'11 2010-07-30 $15.83B
Q4'11 2010-04-30 $12.25B
Q3'11 2010-01-29 $10.50B
Q2'11 2009-10-30 $9.46B
Q1'11 2009-07-31 $7.61B
Q4'11 2009-04-24 $6.23B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (NTAP CIK 0001002047), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

CTEV

Claritev Corp

MGRC

McGRATH RENTCORP

TVRD

TVARDI THERAPEUTICS, INC.